Thomas Andrew Burrow

1.5k total citations
24 papers, 757 citations indexed

About

Thomas Andrew Burrow is a scholar working on Physiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Thomas Andrew Burrow has authored 24 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 9 papers in Organic Chemistry and 8 papers in Molecular Biology. Recurrent topics in Thomas Andrew Burrow's work include Lysosomal Storage Disorders Research (17 papers), Carbohydrate Chemistry and Synthesis (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Thomas Andrew Burrow is often cited by papers focused on Lysosomal Storage Disorders Research (17 papers), Carbohydrate Chemistry and Synthesis (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Thomas Andrew Burrow collaborates with scholars based in United States, Brazil and Argentina. Thomas Andrew Burrow's co-authors include Gregory A. Grabowski, Manisha Balwani, Wujuan Zhang, Kenneth D.R. Setchell, David P. Witte, Barry E. Rosenbloom, Elena Lukina, Timothy M. Cox, Ana María Martins and Benjamin Liou and has published in prestigious journals such as Nature, The Lancet and Blood.

In The Last Decade

Thomas Andrew Burrow

23 papers receiving 718 citations

Peers

Countries citing papers authored by Thomas Andrew Burrow

Since Specialization

Citations

This map shows the geographic impact of Thomas Andrew Burrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Andrew Burrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Andrew Burrow more than expected).

Fields of papers citing papers by Thomas Andrew Burrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Andrew Burrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Andrew Burrow. The network helps show where Thomas Andrew Burrow may publish in the future.

Co-authorship network of co-authors of Thomas Andrew Burrow

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Andrew Burrow. A scholar is included among the top collaborators of Thomas Andrew Burrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Andrew Burrow. Thomas Andrew Burrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I 2021 ·Frontiers in Pediatrics ·(unknown), J. Michael Taylor, (unknown), Kasiani C. Myers, Thomas Andrew Burrow, Lori Luchtman‐Jones, Anna W. Byars, Adrienne M. Hammill, (unknown), Edward R. Smith, James Leach, Sudhakar Vadivelu	1
2	Outcomes of screening for gammopathies in children and adults with Gaucher disease type 1 in a cohort from Brazil and the United States 2020 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·(unknown), (unknown), Thomas Andrew Burrow, (unknown), Laurie Bailey, Paul E. Steele, (unknown), Miguel Islas‐Ohlmayer, Rosane Bittencourt, Ida Vanessa Döederlein Schwartz, Carlos E. Prada	5
3	Multiple Autoimmune Disorders in Aicardi-Goutières Syndrome 2019 ·Pediatric Neurology ·Debopam Samanta, Raghu Ramakrishnaiah, Shelley E. Crary, (unknown), Thomas Andrew Burrow	4
4	Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease 2017 ·Nature ·Manoj K. Pandey, Thomas Andrew Burrow, Reena Rani, Lisa J. Martin, David P. Witte, Kenneth D.R. Setchell, (unknown), Albert Frank Magnusen, Wujuan Zhang, Benjamin Liou, Jörg Köhl, Gregory A. Grabowski	150
5	Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry 2017 ·American Journal of Hematology ·Pramod K. Mistry, Julie L. Batista, Hans C. Andersson, Manisha Balwani, Thomas Andrew Burrow, Joel Charrow, Paige Kaplan, Anzalee Khan, Priya S. Kishnani, Edwin H. Kolodny, Barry E. Rosenbloom, C. Ronald Scott, Neal J. Weinreb	35
6	Immune cells attack and neurodegeneration in Gaucher disease 2016 ·Molecular Genetics and Metabolism ·Manoj K. Pandey, (unknown), (unknown), (unknown), Christina Groß, Charles V. Vorhees, Thomas Andrew Burrow, Gregory A. Grabowski	1
7	C5a drives glucosylceramide accumulation and tissue inflammation in Gaucher disease 2016 ·Immunobiology ·Manoj K. Pandey, Thomas Andrew Burrow, Christina Groß, David P. Witte, Wujuan Zhang, Kenneth D.R. Setchell, Nancy D. Leslie, Gregory A. Grabowski, Jörg Köhl	1
8	Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States 2015 ·Molecular Genetics and Metabolism ·Manisha Balwani, Thomas Andrew Burrow, Joel Charrow, Özlem Göker-Alpan, Paige Kaplan, Priya S. Kishnani, Pramod K. Mistry, Jeremy N. Ruskin, Neal J. Weinreb	53
9	Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial 2015 ·The Lancet ·Timothy M. Cox, Guillermo Drelichman, (unknown), Manisha Balwani, Thomas Andrew Burrow, Ana María Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Ana Cristina Puga	118
10	Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome 2015 ·Journal of Allergy and Clinical Immunology ·Andrew Lindsley, Howard M. Saal, Thomas Andrew Burrow, Robert J. Hopkin, Oleg A. Shchelochkov, Pooja Khandelwal, (unknown), Jack Bleesing, (unknown), Kimberly Risma, Amal Assa’ad, (unknown), Jonathan A. Bernstein	63
11	De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy 2015 ·Annals of Clinical and Translational Neurology ·Sahar Esmaeeli Nieh, (unknown), Minhajuddin Sirajuddin, Brieana Fregeau, Dianalee McKnight, Katrina W. Lexa, Jonathan B. Strober, Christine G. Spaeth, Barbara Hallinan, Nizar Smaoui, John Pappas, Thomas Andrew Burrow, Marie McDonald, (unknown), Esther Leshinsky‐Silver, Dorit Lev, Luba Blumkin, Ronald D. Vale, A. James Barkovich, Elliott H. Sherr	76
12	Combination therapy (eliglustat+velaglucerase alfa) in a pediatric patient with Gaucher disease type 1 and hereditary spherocytosis 2015 ·Molecular Genetics and Metabolism ·Laurie Bailey, Daniel R. Ambruso, Gregory A. Grabowski, Thomas Andrew Burrow	0
13	CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11years of therapy: Clinical, histopathologic, and biochemical findings 2014 ·Molecular Genetics and Metabolism ·Thomas Andrew Burrow, Ying Sun, Carlos E. Prada, Laurie Bailey, Wujuan Zhang, Amanda S. Brewer, Steve W. Wu, Kenneth D.R. Setchell, David P. Witte, Mitchell B. Cohen, Gregory A. Grabowski	57
14	ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals 2014 ·Molecular Genetics and Metabolism ·Timothy M. Cox, Guillermo Drelichman, (unknown), Manisha Balwani, Thomas Andrew Burrow, Ana Maria Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Ana Cristina Puga	1
15	Encore - a Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients Stabilized on Enzyme Replacement Therapy: 24-Month Results 2014 ·Blood ·Barry E. Rosenbloom, Timothy M. Cox, Guillermo Drelichman, (unknown), Manisha Balwani, Thomas Andrew Burrow, Ana María Martins, Elena Lukina, Leorah Ross, Jennifer Angell, (unknown)	2
16	Encephalopathy in a Patient With Short Bowel Syndrome 2013 ·Journal of Parenteral and Enteral Nutrition ·Yael Ziv, Thomas Andrew Burrow, Samuel A. Kocoshis, Scott Pentiuk	1
17	Abnormal pathology findings in a patient with Gaucher disease type 3 treated with enzyme replacement therapy 2013 ·Molecular Genetics and Metabolism ·Thomas Andrew Burrow, David P. Witte, Laurie Bailey, Carlos E. Prada, Ying Sun, Mitchell B. Cohen, Steve W. Wu, Gregory A. Grabowski	1
18	Velaglucerase alfa in the treatment of Gaucher disease type 1 2011 ·Clinical Investigation ·Thomas Andrew Burrow, Gregory A. Grabowski	21
19	Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder 2010 ·Journal of Inherited Metabolic Disease ·Sing‐Chung Li, Chiao‐Ming Chen, Jennifer Goldstein, Jer‐Yuarn Wu, Emmanuelle Lemyre, Thomas Andrew Burrow, Peter B. Kang, (unknown), Deeksha Bali	27
20	The Sanskrit language 1955 ·Americanae (AECID Library) ·Thomas Andrew Burrow	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact